Contrasting Basel Medical Group (NASDAQ:BMGL) and SeaStar Medical (NASDAQ:ICU)

Basel Medical Group (NASDAQ:BMGL) and SeaStar Medical (NASDAQ:ICU) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, dividends, risk, profitability, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of recent recommendations and price targets for Basel Medical Group and SeaStar Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basel Medical Group	1	0	0	0	1.00
SeaStar Medical	1	0	0	0	1.00

SeaStar Medical has a consensus price target of $6.00, indicating a potential upside of 42.86%. Given SeaStar Medical’s higher possible upside, analysts clearly believe SeaStar Medical is more favorable than Basel Medical Group.

Profitability

This table compares Basel Medical Group and SeaStar Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Basel Medical Group	N/A	N/A	N/A
SeaStar Medical	-984.60%	-188.47%	-106.42%

Volatility & Risk

Basel Medical Group has a beta of -0.19, indicating that its stock price is 119% less volatile than the S&P 500. Comparatively, SeaStar Medical has a beta of -1.21, indicating that its stock price is 221% less volatile than the S&P 500.

Institutional and Insider Ownership

1.7% of SeaStar Medical shares are held by institutional investors. 0.7% of SeaStar Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Basel Medical Group and SeaStar Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basel Medical Group	$8.90 million	1.21	-$9.50 million	N/A	N/A
SeaStar Medical	$1.23 million	13.62	-$12.15 million	($8.30)	-0.51

Basel Medical Group has higher revenue and earnings than SeaStar Medical.

Summary

Basel Medical Group beats SeaStar Medical on 6 of the 10 factors compared between the two stocks.

About Basel Medical Group

Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. The company is headquartered in Denver, Colorado.